Congressmembers Higgins, Guthrie, Matsui and Bilirakis Announce Introduction of the Cancer Drug Parity Act

Congressmembers Brian Higgins (D -NY-26), Brett Guthrie (R-KY-2), Doris Matsui (D-CA-6) and Gus Bilirakis (R-FL-12) announced introduction of the Cancer Drug Parity Act, a bipartisan bill requiring health insurance plans that cover intravenous and injectable cancer medications to also cover orally administered cancer medications at the equivalent rate.

“Innovative research has led to more effective and accessible treatment options for Cancer patients, but insurance coverage hasn’t kept pace,” said Congressman Higgins, who also serves as Chair of the House Cancer Caucus.   “The Cancer Drug Parity Act, levels the costs, allowing patients and doctors, not insurance companies, to decide the best course of treatment, removing the cost discrepancy as a factor in cancer care.”

Read press release here